Subscribe
istock-512332386_bakhtiar_zein
bakhtiarzein / iStockphoto.com
26 June 2017Americas

FDA targets barriers to generic competition

The Food and Drug Administration (FDA) has announced its intention to target the barriers to generic drug competition.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FDA issues new guidance to boost generic competition
3 October 2017   The US Food and Drug Administration has issued new guidance as part of its bid to target the barriers to generic drug competition.
Americas
FDA identifies companies ‘potentially blocking access’ to drug samples
21 May 2018   The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.
Americas
USFDA to modernise generic review with $37.6m funding
19 June 2018   The US Food and Drug Administration is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
FDA issues new guidance to boost generic competition
3 October 2017   The US Food and Drug Administration has issued new guidance as part of its bid to target the barriers to generic drug competition.
Americas
FDA identifies companies ‘potentially blocking access’ to drug samples
21 May 2018   The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.
Americas
USFDA to modernise generic review with $37.6m funding
19 June 2018   The US Food and Drug Administration is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics.

More on this story

Americas
FDA issues new guidance to boost generic competition
3 October 2017   The US Food and Drug Administration has issued new guidance as part of its bid to target the barriers to generic drug competition.
Americas
FDA identifies companies ‘potentially blocking access’ to drug samples
21 May 2018   The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.
Americas
USFDA to modernise generic review with $37.6m funding
19 June 2018   The US Food and Drug Administration is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York